Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a Phase 1 safety and pharmacokinetics study registration with no results posted; it describes planned enrollment and design only, typical of early-stage clinical development.
This is an active registry record for an ongoing interventional study with no results posted; it describes a planned behavioral intervention in a specific population without efficacy data.
Phase 2 interventional trial in an active but unrecruitment stage with no results reported in this registry record; design and endpoints are specified but outcome data are absent.
Phase 1 dose-escalation trial of a novel bispecific antibody in solid tumors; designed to establish safety and tolerability with preliminary efficacy assessment, not yet recruiting and results not reported.
Preclinical proof-of-concept study in xenograft models demonstrating enhanced anti-tumor activity with a novel CD2-targeted bispecific; no clinical efficacy or safety data provided.